These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26899580)

  • 1. Peripheral Immune Signatures in Alzheimer Disease.
    Goldeck D; Witkowski JM; Fülop T; Pawelec G
    Curr Alzheimer Res; 2016; 13(7):739-49. PubMed ID: 26899580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased tauopathy drives microglia-mediated clearance of beta-amyloid.
    Chen W; Abud EA; Yeung ST; Lakatos A; Nassi T; Wang J; Blum D; Buée L; Poon WW; Blurton-Jones M
    Acta Neuropathol Commun; 2016 Jun; 4(1):63. PubMed ID: 27339073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
    Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
    J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological aspects and anti-amyloid strategy for Alzheimer's dementia.
    Liščić RM
    Arh Hig Rada Toksikol; 2013 Dec; 64(4):603-8. PubMed ID: 24384767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
    Bloom GS
    JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
    Baik SH; Kang S; Son SM; Mook-Jung I
    Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathways by which Abeta facilitates tau pathology.
    Blurton-Jones M; Laferla FM
    Curr Alzheimer Res; 2006 Dec; 3(5):437-48. PubMed ID: 17168643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active full-length DNA Aβ
    Rosenberg RN; Fu M; Lambracht-Washington D
    Alzheimers Res Ther; 2018 Nov; 10(1):115. PubMed ID: 30454039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.
    Takahashi RH; Nagao T; Gouras GK
    Pathol Int; 2017 Apr; 67(4):185-193. PubMed ID: 28261941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglia as a potential bridge between the amyloid beta-peptide and tau.
    Kitazawa M; Yamasaki TR; LaFerla FM
    Ann N Y Acad Sci; 2004 Dec; 1035():85-103. PubMed ID: 15681802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abeta species removal after abeta42 immunization.
    Nicoll JA; Barton E; Boche D; Neal JW; Ferrer I; Thompson P; Vlachouli C; Wilkinson D; Bayer A; Games D; Seubert P; Schenk D; Holmes C
    J Neuropathol Exp Neurol; 2006 Nov; 65(11):1040-8. PubMed ID: 17086100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell mediators of inflammation in the Alzheimer disease brain.
    Akiyama H; Arai T; Kondo H; Tanno E; Haga C; Ikeda K
    Alzheimer Dis Assoc Disord; 2000; 14 Suppl 1():S47-53. PubMed ID: 10850730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease plaques and tangles: cemeteries of a pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction.
    Carter CJ
    Neurochem Int; 2011 Feb; 58(3):301-20. PubMed ID: 21167244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroinflammatory signals in Alzheimer disease and APP/PS1 transgenic mice: correlations with plaques, tangles, and oligomeric species.
    López-González I; Schlüter A; Aso E; Garcia-Esparcia P; Ansoleaga B; LLorens F; Carmona M; Moreno J; Fuso A; Portero-Otin M; Pamplona R; Pujol A; Ferrer I
    J Neuropathol Exp Neurol; 2015 Apr; 74(4):319-44. PubMed ID: 25756590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglia cells are the driving force in fibrillar plaque formation, whereas astrocytes are a leading factor in plague degradation.
    Wegiel J; Wang KC; Tarnawski M; Lach B
    Acta Neuropathol; 2000 Oct; 100(4):356-64. PubMed ID: 10985692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral amyloid-beta protein accumulation with aging in cotton-top tamarins: a model of early Alzheimer's disease?
    Lemere CA; Oh J; Stanish HA; Peng Y; Pepivani I; Fagan AM; Yamaguchi H; Westmoreland SV; Mansfield KG
    Rejuvenation Res; 2008 Apr; 11(2):321-32. PubMed ID: 18341428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The possible role of the immune system in Alzheimer's disease.
    Marx F; Blasko I; Pavelka M; Grubeck-Loebenstein B
    Exp Gerontol; 1998; 33(7-8):871-81. PubMed ID: 9951630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.